The Ia antigens in mice and the HLA-DR antigens in man play a critical role in the interaction of T lymphocytes and macrophages in antigen recognition (1, 2). In contrast to the murine I region, resolution of the complexity of the human HLA-D/ DR region has been difficult because of limited information from genetic recombination. Furthermore, the exact nature of the determinants involved in cellular interactions is uncertain because they can be defined only with polyclonal antisera. Clarification of the role of DR antigens in various functions controlled by this region would be facilitated by monoclonal antibodies directed against polymorphic determinants. Whereas many monoclonal antibodies precipitating DR-like antigens have been described, the relationship between these molecules and DR antigens defined by alloantisera remains unclear, riaainly because thesd xenogeneic antibodies detect monomorphic (3) (4) (5) (6) , supertypic (4, 6) , or other determinants on DR-like molecules (7) . To date, no monoclonal antibody directed against an epitope with the genetic and biochemical characteristics of a single DR alloantigen has been reported (8, 9) . In this report, we characterized a mouse monoclonal antibody (16.23 ) detecting a DR-type molecule that is correlated with the HLA-DR3 alloantigen.
Materials and Methods
Reagents. The origin and maintenance of the cell lines have been described (10) . The Rewi cell line was produced by Epstein-Barr virus transformation of peripheral blood lymphocytes (PBL) 1 from a homozygous HLA-Dwl, DR1 donor. The cytotoxic monoclonal antibody 16.23 (IgG3) was obtained from a BALB/c mouse immunized with a single injection of human melanoma cell line Mel JuSo. When tested in a binding assay with a panel of 27 cell lines, it bound only to the immunizing tumor and to an autologous B cell line (10) . The JuSo B cell line and PBL were typed as HLA A1, 2; B7, 8; Cw-; DR2, 3. The specificities and numbers of individual HLA-D homozygous typing cells (HTC) used were: HLA-Dwl (5), Dw2 (7), Dw3 (5), Dw4 (2), Dw5 (1), Dw6 (3), Dw7 (1), Dw8 (~), Dw9 (2), and undefined (1). The HLA-A, * Supported by the Deutsche Forschungsgemeinschaft, Bonn, through the Sonderforschungsbereich 37 (B9). preparation, immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and autoradiography were performed as described (10) . Iodinated HLA-DR-Iike antigens were eluted from 16.23-SPA Sepharose (10) with 8 M urea (RT, 1 h), and the subunits were separated by SDS-PAGE (10%) under nonreducing conditions. The unfixed gel was dried and exposed for 4-6 h. Three bands of radioactivity were obtained, two of which (Mr 35,000 and 25,000) were shown by subsequent SDS-PAGE to correspond to the a (Mr 37,000) and fl (Mr 31,000) subunits. The 35 and 25 kd bands were eluted from the gel in 0.01 M Tris-HCl, pH 8, containing 0.1% Nonidet P-40, 1 mM benzamidine HCI, I mM phenyl methyl sulfonyl fluoride (PMSF), and 1% bovine serum albumin (BSA) (7 h at 4°C). 70-89% of the radioactivity was recovered. To assess antibody binding, subunits in 50% fetal calf serum (FCS) were incubated with myeloma supernatant MPC 11-SpA Sepharose (1 h, 4°C, 10/tl packed gel) followed by 16.23-SPA Sepharose (2 h, 4°C, 10/tl packed gel). The bound radioactivity was measured and analyzed on a 10% SDS-PAGE under reducing conditions. The material in each lane was estimated by scanning the autoradiographs at 405 nm (ISCO gel scanner, model 1310, type 6 optical unit; ISCO, Instrumentation Specialties Co., Lincoln, NE). In an analysis of PBL from seven unrelated individuals selected from an HLAtyped panel, only two reacted with 16.23, suggesting that the antigen detected is polymorphic in the population. Subsequent analysis of four families established that the antigen defined by 16.23 segregates in tight linkage with HLA (Table I) .
Western Blotting and Detection of Antigen in Cell Lysates
Because the tissue distribution suggested that antibody 16.23 might detect a DR antigen, 32 unrelated HLA-DR typed individuals (specifieities 1-8) and 28 HTC (Dw specificities 1-9) were analyzed. A strong association between reactivity with 16.23 and the HLA,Dw/DR3 phenotype was found (Table II) Linkage was determined using the method of lod scores (0~. = 0.0, lod score = 3.607; odds, 4,000:1; zLa-= 1.506 zLe = 1.80, and zw6 = 0.301) (14) . 
Subunit Localization of the HLA-DR3-associated Determinant.
To localize the epitope defined by this antibody, iodinated antigen was isolated from JuSo B cells, and the subunits were separated and tested directly for reactivity with 16.23. Antibody 16.23 and control Ig M P C 11 bound equivalent amounts of the a subunit (Fig. 2) . In contrast, 16.23 bound >50% of the fl chain radioactivity, whereas MPC11 binding remained at background levels. This bound material was eluted and analyzed in SDS-PAGE (Fig. 2) . Labeled polypeptides were observed only in the 16.23-fl chain eluate, and this material migrated in the position of the smaller molecular weight fl subunit.
In a second approach, the electrophoretically separated unlabeled cell lysate proteins from JuSo (DR2, 3) and Rewi (DR 1) were transferred to nitrocellulose filters. These filters were then incubated with 16.23, M P C 11, or rabbit antiserum against D R fl chains, followed by [I125]SPA. Location of the a-fl complex and the separated a and fl subunits was determined by running immunoprecipitated 125I-labeled antigen on the same gel. In lysates containing 1% SDS and heated to 45°(2, the majority of the 16.23-binding activity was found in a position corresponding to the undissociated t~-fl complex, although substantial binding was also observed to a band in the position of the fl chain (Fig. 3, lane c Discussion The unique allotypic specificity of antibody 16.23 should help to resolve several problems that have not yet been clarified in studies using alloantisera or the existing monoclonal antibodies. Although two-dimensional electrophoresis (15, 16) and tryptic digest peptide mapping (17, 18) have demonstrated far more heterogeneity in the light (fl) subunit than in the heavy (a) subunit, the actual location of the HLA-DR allotypic determinants has remained unclear. Analysis of mouse-human somatic cell hybrids indicated that the allotypic determinants were associated with the large molecular weight (a) subunit (19) . In two independent studies, incubation of alloantisera with isolated subunits resulted in binding exclusively to the a chains (20) xenoantisera provided indirect evidence that the DR3 determinant(s) were present on the heavy (et) chain (22) . Whereas interpretation of these results is complicated by the use of polyclonal antisera, discordant observations could be explained by the existence of several alloantigen-associated determinants, some of which are present on the a and others on the fl subunits but that are inherited together because of linkage disequilibrium and are detected to varying degrees by different alloantisera. Using two independent approaches, a n t i b o d y 16.23 was shown to bind to the smaller 31,000 mol wt fl subunit, clearly establishing the control of this subunit by H L A a n d demonstrating that it carries an epitope of the DR3 phenotype. T h e relationship of the 16.23-bearing subunit to the fl subunits bearing m o n o m o r p h i c a n d supertypic determinants defined by other monoclonal antibodies (3, 6) remains to be investigated.
Monoclonal antibodies directed against individual allotypes will be useful in dissecting the serological cross-reactivities that have been observed between different H L A specificities. In an analysis of more than 120 individuals from the G e r m a n population, a n t T h e lack of reactivity with DRw5, 7, and 8 individuals shows that this a n t i b o d y does not correlate with the broad M B a n d M T specificities, MB2 or M T 2 (23), and suggests that the defined epitope is shared between DR3 and at least a portion of D R w 6 cells. O p e r a t i o n a l l y monospecific alloantisera for D R w 6 are not available (24) , and assignment of this specificity is presently based on reactivity with three groups of multispecific antisera, one of which also includes activity against H L A -D R 3 (25) . An analysis of the molecules precipitated by a n t i b o d y 16.23 from cells of these two phenotypes should clarify the relationship between H L A -D R 3 and DRw6.
Finally, antibody 16.23 is an important tool for examining the expression of a clearly defined HLA-DR allospecificity on different cell types, particularly on macrophages, T and B lymphocytes, and tumor cells, as well as for studying its functional involvement in cellular interactions.
Summary
A murine monoclonal antibody directed against a human B cell surface antigen with the characteristics of HLA-DR is described. The antigen detected is tightly linked to HLA and is correlated with the alloantigen HLA-Dw/DR3. Reactivity with a fraction of Dw/DRw6 cells is also observed. The determinant recognized by this antibody has been shown to be present on the smaller molecular weight fl subunit of the HLA-DR antigen.
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